Atlantis grabs $9.8m in series D:
This article was originally published in Clinica
Cambridge, Massachusetts-based dental implant developer Atlantis Components has raised $9.8m in a series D financing. The round included the participation of new investor Signet Healthcare Partners as well as its existing shareholders, which include, among others ABV, CID Equity Capital and Ironwood Equity Fund. Proceeds from the financing will go towards expanding Atlantis' market presence. The company produces patient-specific dental implants using 3D digital imaging and integrated manufacturing methods.
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.